Mark Weiss

TitleProfessor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address834 Chestnut Street
Philadelphia PA 19107
Phone215-503-5923
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01CA067823     (WEISS, MARK A)Aug 1, 1995 - Jul 31, 2000
    NIH
    THERAPEUTIC STRATEGIES IN CLL WITH CURATIVE INTENT
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pan J, Ghimire S, Alpdogan SO, Chapman A, Carabasi M, DiMeglio M, Gong J, Martinez-Outschoorn U, Rose L, Ramirez M, Wagner JL, Weiss M, Flomenberg N, Pro B, Porcu P, Filicko-OHara J, Gaballa S. Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2020 Nov 04; 1-8. PMID: 33146052.
      Citations:    
    2. Kasner MT, Mick R, Jeschke GR, Carabasi M, Filicko-O'Hara J, Flomenberg N, Frey NV, Hexner EO, Luger SM, Loren AW, Mangan JK, Wagner JL, Weiss M, Carroll M, Perl AE. Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition. Invest New Drugs. 2018 Apr 02. PMID: 29607465.
      Citations:    
    3. Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick ED, Kiselev P, Sharman JP. Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States. BMC Cancer. 2017 Mar 16; 17(1):198. PMID: 28302090.
      Citations:    
    4. Mato A, Nabhan C, Kay NE, Weiss MA, Lamanna N, Kipps TJ, Grinblatt DL, Flinn IW, Kozloff MF, Flowers CR, Farber CM, Kiselev P, Swern AS, Sullivan K, Flick ED, Sharman JP. Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres. Br J Haematol. 2016 Dec; 175(5):892-903. PMID: 27861736.
      Citations:    
    5. Gaballa S, Palmisiano N, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Kraft WK, Leiby B, Martinez-Outschoorn U, O'Hara W, Pro B, Rudolph S, Sharma M, Wagner JL, Weiss M, Flomenberg N, Grosso D. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Jan; 22(1):141-8. PMID: 26415558.
      Citations:    
    6. Grosso DA, Hess RC, Weiss MA. Immunotherapy in acute myeloid leukemia. Cancer. 2015 Aug 15; 121(16):2689-704. PMID: 26095886.
      Citations:    
    7. Grosso D, Gaballa S, Alpdogan O, Carabasi M, Filicko-O'Hara J, Kasner M, Martinez-Outschoorn U, Wagner JL, O'Hara W, Rudolph S, Chervoneva I, Colombe B, Farley PC, Flomenberg P, Pro B, Sharma M, Shi W, Weiss M, Flomenberg N. A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage disease. Biol Blood Marrow Transplant. 2015 Apr; 21(4):646-52. PMID: 25542159.
      Citations:    
    8. Bruminhent J, Wang ZX, Hu C, Wagner J, Sunday R, Bobik B, Hegarty S, Keith S, Alpdogan S, Carabasi M, Filicko-O'Hara J, Flomenberg N, Kasner M, Outschoorn UM, Weiss M, Flomenberg P. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Sep; 20(9):1329-34. PMID: 24792871.
      Citations:    
    9. Hu C, Sunday R, Bruminhent J, Bobik B, Wagner J, Weiss M, Flomenberg P, Wang ZX. Investigation of a Clostridium difficile cluster by multilocus sequence typing in a bone marrow transplant unit. Am J Infect Control. 2014 Jun; 42(6):691-3. PMID: 24690456.
      Citations:    
    10. Pathak P, Hess R, Weiss MA. Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature. Ther Adv Hematol. 2014 Feb; 5(1):18-24. PMID: 24490021.
      Citations:    
    11. Grosso D, Weiss MA. Posttreatment interleukin-2 in patients with acute myeloid leukemia: The end of a long road for patients and clinical trials? Cancer. 2014 Apr 1; 120(7):940-1. PMID: 24382703.
      Citations:    
    12. Lowery RK, Uribe G, Jimenez EB, Weiss MA, Herrera KJ, Regueiro M, Herrera RJ. Neanderthal and Denisova genetic affinities with contemporary humans: introgression versus common ancestral polymorphisms. Gene. 2013 Nov 1; 530(1):83-94. PMID: 23872234.
      Citations:    
    13. Lamanna N, Heffner LT, Kalaycio M, Schiller G, Coutre S, Moore J, Seiter K, Maslak P, Panageas K, Golde D, Weiss MA. Treatment of adults with acute lymphoblastic leukemia: Do the specifics of the regimen matter?: Results from a prospective randomized trial. Cancer. 2013 Mar 15; 119(6):1186-94. PMID: 23280086.
      Citations:    
    14. Kasner MT, Weiss M. Treatment of adult ALL: more questions than answers. Oncology (Williston Park). 2012 Sep; 26(9):865, 869-70. PMID: 23061345.
      Citations:    
    15. Grosso D, Carabasi M, Filicko-O'Hara J, Kasner M, Wagner JL, Colombe B, Cornett Farley P, O'Hara W, Flomenberg P, Werner-Wasik M, Brunner J, Mookerjee B, Hyslop T, Weiss M, Flomenberg N. A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing. Blood. 2011 Oct 27; 118(17):4732-9. PMID: 21868572.
      Citations:    
    16. Mahipal A, Weiss M. The addition of rituximab to fludarabine and cyclophosphamide improves progression-free survival in patients with previously treated chronic lymphocytic leukemia. Curr Oncol Rep. 2010 Nov; 12(6):352-4. PMID: 20809225.
      Citations:    
    17. Tomaske M, Candinas R, Weiss M, Bauersfeld U. Safety and efficacy of paediatric outpatient radiofrequency catheter ablations. Int J Cardiol. 2011 May 5; 148(3):276-9. PMID: 19945182.
      Citations:    
    18. Lamanna N, Weiss MA. Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2009 Oct; 4(4):185-6. PMID: 20425406.
      Citations:    
    19. Lamanna N, Jurcic JG, Noy A, Maslak P, Gencarelli AN, Panageas KS, Heaney ML, Brentjens RJ, Golde DW, Scheinberg DA, Zelenetz AD, Weiss MA. Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. J Clin Oncol. 2009 Feb 1; 27(4):491-7. PMID: 19075280.
      Citations:    
    20. Lamanna N, Weiss MA. Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia. Curr Oncol Rep. 2008 Sep; 10(5):363-4. PMID: 18706262.
      Citations:    
    21. Sauter C, Lamanna N, Weiss MA. Pentostatin in chronic lymphocytic leukemia. Expert Opin Drug Metab Toxicol. 2008 Sep; 4(9):1217-22. PMID: 18721115.
      Citations:    
    22. Horn DL, Fishman JA, Steinbach WJ, Anaissie EJ, Marr KA, Olyaei AJ, Pfaller MA, Weiss MA, Webster KM, Neofytos D. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections. Diagn Microbiol Infect Dis. 2007 Dec; 59(4):407-14. PMID: 17888614.
      Citations:    
    23. Lamanna N, Weiss MA. Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia. Curr Oncol Rep. 2007 Sep; 9(5):335-6; discussion 336. PMID: 17706160.
      Citations:    
    24. Landau H, Weiss MA. Clinical trials report. Minimal residual disease quantification in adult acute lymphoblastic leukemia. Curr Oncol Rep. 2006 Sep; 8(5):323-4. PMID: 16901393.
      Citations:    
    25. Lamanna N, Weiss MA. Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia. Semin Hematol. 2006 Apr; 43(2 Suppl 2):S44-9. PMID: 16549114.
      Citations:    
    26. Lamanna N, Kalaycio M, Maslak P, Jurcic JG, Heaney M, Brentjens R, Zelenetz AD, Horgan D, Gencarelli A, Panageas KS, Scheinberg DA, Weiss MA. Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. J Clin Oncol. 2006 Apr 1; 24(10):1575-81. PMID: 16520464.
      Citations:    
    27. Rosenblatt M, Caridi JG, Hakki FZ, Jackson J, Kapoian T, Martin SP, Moran J, Pedan A, Reese WJ, Ross JP, Ross J, Rushton F, Schwab SJ, Soundararajan R, Stainken B, Weiss MA, Work J, Yegge J. Efficacy and safety results with the LifeSite hemodialysis access system versus the Tesio-Cath hemodialysis catheter at 12 months. J Vasc Interv Radiol. 2006 Mar; 17(3):497-504. PMID: 16567674.
      Citations:    
    28. Kapusta LR, Weiss MA, Ramsay J, Lopez-Beltran A, Srigley JR. Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol. 2003 May; 27(5):658-66. PMID: 12717250.
      Citations:    
    29. Weiss MA, Maslak PG, Jurcic JG, Scheinberg DA, Aliff TB, Lamanna N, Frankel SR, Kossman SE, Horgan D. Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. J Clin Oncol. 2003 Apr 1; 21(7):1278-84. PMID: 12663715.
      Citations:    
    30. Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer. 2003 Feb 15; 97(4):1025-32. PMID: 12569602.
      Citations:    
    31. Schwab SJ, Weiss MA, Rushton F, Ross JP, Jackson J, Kapoian T, Yegge J, Rosenblatt M, Reese WJ, Soundararajan R, Work J, Ross J, Stainken B, Pedan A, Moran JA. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int. 2002 Sep; 62(3):1026-33. PMID: 12164887.
      Citations:    
    32. Weiss MA, Aliff TB, Tallman MS, Frankel SR, Kalaycio ME, Maslak PG, Jurcic JG, Scheinberg DA, Roma TE. A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer. 2002 Aug 1; 95(3):581-7. PMID: 12209751.
      Citations:    
    Weiss's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (121)
    Explore
    _
    Co-Authors (24)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _